Back
Larimar Therapeutics Vs. SoftBank Group Industry Stock Comparison
Sell
37
LRMR
Larimar Therapeutics
Last Price:
6.63
Seasonality Move:
9.02%
Sell
45
SFTBY
SoftBank Group
Last Price:
29.86
Seasonality Move:
1.61%
Sell
37
Larimar Therapeutics (LRMR)
is a Sell
Is Larimar Therapeutics a Buy, Sell or Hold?
- The current Larimar Therapeutics [LRMR] share price is $6.65. The Score for LRMR is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- LRMR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
SoftBank Group (SFTBY)
is a Sell
Is SoftBank Group a Buy, Sell or Hold?
- The current SoftBank Group [SFTBY] share price is $29.86. The Score for SFTBY is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- SFTBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LRMR Stock Price Chart
What is Larimar Therapeutics's stock price today?
-
The Larimar Therapeutics share price today is $6.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LRMR is experiencing slight buying pressure.
SFTBY Stock Price Chart
What is SoftBank Group's stock price today?
-
The SoftBank Group share price today is $29.86
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SFTBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
LRMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.35 | Sell |
| Relative Strength Index (14 RSI): | 44.51 | Sell |
| Chaikin Money Flow: | 254831 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.38 - 7.7) | Sell |
| Bollinger Bands (100): | (6.94 - 9.08) | Sell |
SFTBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.27 | Buy |
| Relative Strength Index (14 RSI): | 53.06 | Buy |
| Chaikin Money Flow: | 400281 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.84 - 30.42) | Buy |
| Bollinger Bands (100): | (27.1 - 32.74) | Sell |
LRMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.44 | Buy |
| 20-day SMA: | 6.82 | Sell |
| 50-day SMA: | 7.49 | Sell |
| 200-day SMA: | 7.66 | Sell |
| 8-day EMA: | 6.53 | Buy |
| 20-day EMA: | 6.82 | Sell |
| 50-day EMA: | 7.36 | Sell |
| 200-day EMA: | 7.22 | Sell |
SFTBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.89 | Sell |
| 20-day SMA: | 29.58 | Buy |
| 50-day SMA: | 28.51 | Buy |
| 200-day SMA: | 27.85 | Buy |
| 8-day EMA: | 29.75 | Buy |
| 20-day EMA: | 29.52 | Buy |
| 50-day EMA: | 29.38 | Buy |
| 200-day EMA: | 27.81 | Buy |
Larimar Therapeutics Earnings Growth & LRMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.69 per share, and a decrease next year of $0.45 per share.
SoftBank Group Earnings Growth & SFTBY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Larimar Therapeutics Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
SoftBank Group Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||